Virtus LifeSci Biotech Products ETF Rating $96.05 +1.79 (+1.90%) As of 08/4/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.63Holdings in BBP have an aggregate rating of Moderate Buy based on 326 analyst ratings issued in the past year covering 25 companies (42.3% of the portfolio).BBP Aggregate Price Target$96.05High Prediction$96.05Average Prediction$96.05Low Prediction$96.05Holdings in BBP have an aggregate price target of $96.05 and a range of $96.05 to $96.05 covering 25 companies (42.3% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBP Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.22%CRNXCrinetics Pharmaceuticals$83.86+0.1%2.1745 of 5 stars2.24$81.00 -3.4%17Earnings Report1.95%VSTMVerastem$5.81+2.1%3.7883 of 5 stars2.91$14.40 147.8%11Upcoming Earnings1.78%AGIOAgios Pharmaceuticals$31.60+3.5%2.8385 of 5 stars2.40$40.88 29.4%10Earnings ReportAnalyst Revision1.72%XERSXeris Biopharma$8.19+0.7%3.9079 of 5 stars2.57$10.80 31.9%7News CoverageUpcoming EarningsInsider Trade1.70%PTGXProtagonist Therapeutics$135.81+2.7%1.5871 of 5 stars2.94$123.00 -9.4%17Positive News1.66%GERNGeron$1.35+5.1%2.628 of 5 stars2.20$4.00 197.4%5Positive NewsGap Up1.65%SNDXSyndax Pharmaceuticals$19.08-0.8%2.6687 of 5 stars2.92$42.55 123.0%13News CoverageEarnings Report1.64%MRNAModerna$57.08+3.5%1.5091 of 5 stars1.88$42.13 -26.2%17Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision1.63%KNSAKiniksa Pharmaceuticals International$75.99+3.5%3.946 of 5 stars2.90$87.38 15.0%101.63%RIGLRigel Pharmaceuticals$38.70+3.4%4.1629 of 5 stars2.33$54.50 40.8%6News CoverageEarnings Report1.62%IOVAIovance Biotherapeutics$4.36+0.9%2.6037 of 5 stars2.30$8.43 93.3%10Upcoming Earnings1.61%BBIOBridgeBio Pharma$82.07+2.6%3.1087 of 5 stars2.83$95.21 16.0%23Positive NewsUpcoming EarningsInsider Trade1.61%ACADACADIA Pharmaceuticals$27.15+6.0%4.3057 of 5 stars2.67$32.31 19.0%18News CoveragePositive NewsEarnings Report1.60%IMCRImmunocore$33.24+2.5%3.41 of 5 stars2.36$56.29 69.3%11Upcoming EarningsAnalyst Forecast1.60%RYTMRhythm Pharmaceuticals$105.78+2.9%3.4289 of 5 stars2.78$138.73 31.2%18Trending NewsEarnings ReportHigh Trading Volume1.59%ASNDAscendis Pharma A/S$244.59+0.5%4.8415 of 5 stars3.05$296.72 21.3%19Positive NewsUpcoming Earnings1.59%KURAKura Oncology$9.47+3.0%3.3313 of 5 stars2.69$25.46 168.9%13Upcoming EarningsGap Up1.59%RAREUltragenyx Pharmaceutical$25.81+3.2%3.6041 of 5 stars2.83$57.94 124.5%18Trending NewsEarnings ReportAnalyst Forecast1.58%MIRMMirum Pharmaceuticals$104.33-0.2%3.367 of 5 stars2.93$143.40 37.4%15Positive News1.57%ZLABZai Lab$18.49+1.7%3.4365 of 5 stars2.71$40.00 116.3%7News CoverageUpcoming Earnings1.57%LGNDLigand Pharmaceuticals$300.79+3.0%4.3753 of 5 stars2.88$326.00 8.4%8Positive NewsUpcoming EarningsAnalyst ForecastInsider TradeGap Up1.56%ONCBeOne Medicines$323.01+2.9%4.6573 of 5 stars2.88$394.00 22.0%16Insider TradeGap Up1.56%NUVBNuvation Bio$6.46+4.8%3.73 of 5 stars2.64$12.88 99.5%11Upcoming Earnings1.55%ARQTArcutis Biotherapeutics$26.03+0.3%3.7205 of 5 stars2.50$34.00 30.6%8Positive News1.53%MDGLMadrigal Pharmaceuticals$507.56+5.3%4.0285 of 5 stars2.78$689.93 35.9%18Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap Up This page (NYSEARCA:BBP) was last updated on 8/5/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredWhere to Put $100 Before Trump's New Tech Law Rolls OutThe Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBP Stock Alerts